Description
COVID longue
Lignes directrices canadiennes
Dernière mise à jour du 17 juillet 2025
Nouvelles publications scientifiques
- Symptom-based clusters in people with post-COVID-19 condition (PCC)on 17 juillet 2026
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. […]
- Impact of COVID-19 on Subsequent Lung Function in Childhood: A Systematized Reviewon 17 juillet 2026
Health Sci Rep. 2026 Jul 7;9(7):e72793. doi: 10.1002/hsr2.72793. eCollection 2026 Jul.ABSTRACTBACKGROUND AND AIMS: The SARS-CoV-2 infection can lead to transiently altered lung function in adults, […]
- Autonomic Dysfunction in Long COVID Is Distinct From Pure Autonomic Failureon 17 juillet 2026
J Am Coll Cardiol. 2026 Jul 14;88(2):245-247. doi: 10.1016/j.jacc.2026.03.177.NO ABSTRACTPMID:42454777 | DOI:10.1016/j.jacc.2026.03.177
- Reshaping long COVID care through patient-reported needson 17 juillet 2026
BMC Infect Dis. 2026 Jul 7. doi: 10.1186/s12879-026-13773-x. Online ahead of print.ABSTRACTBACKGROUND: Long COVID is a multisystem condition characterized by persistent or fluctuating symptoms […]
- Building the evidence base for long COVID treatmentson 17 juillet 2026
Lancet Infect Dis. 2026 Jul 8:S1473-3099(26)00350-6. doi: 10.1016/S1473-3099(26)00350-6. Online ahead of print.NO ABSTRACTPMID:42419332 | DOI:10.1016/S1473-3099(26)00350-6
- Post-COVID: a specific neuropsychological profile in performance deficitson 17 juillet 2026
J Neural Transm (Vienna). 2026 Jun 29. doi: 10.1007/s00702-026-03209-w. Online ahead of print.ABSTRACTBACKGROUND: SARS-CoV-2 is frequently associated with cognitive impairment. When symptoms persist […]
- "That's not my silo": Navigating fragmented long COVID care in the mid-Atlantic United Stateson 17 juillet 2026
SSM Qual Res Health. 2026 Jun;9:100746. doi: 10.1016/j.ssmqr.2026.100746. Epub 2026 Mar 16.ABSTRACTBACKGROUND: Long COVID is a chronic illness affecting multiple organ systems, which can be at odds […]
- A randomized controlled trial of adjunctive speleotherapy in asthma, COPD and long COVIDon 2 juin 2026
Sci Rep. 2026 May 22;16(1):15986. doi: 10.1038/s41598-026-52301-4.ABSTRACTSpeleotherapy (underground climate therapy) is a non-pharmacological intervention for chronic respiratory diseases. This […]
- Long Covid and Digital Health in Switzerland: Potentials and Limitationson 2 juin 2026
Stud Health Technol Inform. 2026 May 21;336:2284-2288. doi: 10.3233/SHTI260677.ABSTRACTPost-COVID-19 (or Long Covid) presents a complex and persistent health challenge affecting a growing number of […]
- Good? A very long COVID-19on 2 juin 2026
J Hum Immun. 2025 Dec 26;2(1):e20250178. doi: 10.70962/jhi.20250178. eCollection 2026 Jan 5.ABSTRACTWe report a case of chronic SARS-CoV-2 infection resulting from impaired B cell-mediated immunity […]
- Symptom-based rehabilitation in people with post-COVID-19 condition (RELOAD study): a randomised controlled trialon 2 juin 2026
BMJ Open Respir Res. 2026 May 20;13(1):e004177. doi: 10.1136/bmjresp-2026-004177.ABSTRACTRATIONALE: Post-COVID condition (PCC) is characterised by persistent symptoms that impair health-related […]
- Divergent Long-Term Recovery After Long COVID in Tobacco Use Disorder and Healthy Controls: A Longitudinal Studyon 2 juin 2026
Nicotine Tob Res. 2026 May 18:ntag112. doi: 10.1093/ntr/ntag112. Online ahead of print.ABSTRACTINTRODUCTION: Although tobacco use disorder (TUD) and long COVID (LC) have been associated to […]
- Characterization of post-COVID syndrome by self-perceived symptom severity stratified by infection wave: beyond COVID, a prospective, multicenter cohort study in Germanyon 2 juin 2026
Infection. 2026 May 18. doi: 10.1007/s15010-026-02819-6. Online ahead of print.ABSTRACTBACKGROUND: Post-COVID syndrome (PCS) refers to persistent or new-onset symptoms 3 months after SARS-CoV-2 […]
- Integrated immune, apoptotic and mitochondrial gene dysregulation in Long COVID and their association with symptom burden at 10 months post-infectionon 2 juin 2026
Sci Rep. 2026 May 15. doi: 10.1038/s41598-026-53455-x. Online ahead of print.ABSTRACTLong COVID is characterized by persistent symptoms following acute SARS-CoV-2 infection, yet its biological […]
- The role of the endothelium in long COVIDon 2 juin 2026
Vascul Pharmacol. 2026 May 14:107654. doi: 10.1016/j.vph.2026.107654. Online ahead of print.ABSTRACTSARS-CoV2 infection significantly increases the risk of cardiovascular events through multiple […]
- Long COVID and risk of incident cardiovascular disease: a prospective cohort study using the Multimorbidity Integrated Registry Across Care Levels in Stockholm (MIRACLE-S) cohorton 15 mai 2026
EClinicalMedicine. 2026 Apr 1;94:103846. doi: 10.1016/j.eclinm.2026.103846. eCollection 2026 Apr.ABSTRACTBACKGROUND: Long COVID has emerged as a global health challenge, with increasing evidence of […]
- Evaluating a Digital Patient Reported Outcome Measure for Long COVID in a Community Rehabilitation Serviceon 15 mai 2026
J Prim Care Community Health. 2026 Jan-Dec;17:21501319261437896. doi: 10.1177/21501319261437896. Epub 2026 May 4.ABSTRACTBACKGROUND: Long COVID presents with a wide range of persistent symptoms which […]
- The neuropsychiatric features of Long COVID in older adults and the potential association with neuroinflammation: Preliminary observations in a small cohorton 15 mai 2026
J Neurol Sci. 2026 Apr 11;486:125915. doi: 10.1016/j.jns.2026.125915. Online ahead of print.ABSTRACTBACKGROUND: The underlying mechanism of neuropsychiatric features of Long COVID remains unclear; […]
- Outcomes of Patients with Neurocognitive Symptoms Attending a Long COVID Clinic: A Longitudinal Cohort Studyon 15 mai 2026
Committee on Examining the Working Definition for Long COVID, Board on Health Sciences Policy, Board on Global Health, Health and Medicine Division, National Academies of Sciences, Engineering, and […]
- Addressing the Costs and Care for Long COVIDon 10 avril 2026
OECD Featured topics Agriculture and fisheries Climate change Development Digital Economy Education and skills Employment Environment Finance and investment Governance Health Industry, […]
Maladie de Lyme
- The current landscape and future directions of Lyme disease vaccineson 17 juillet 2026
Virulence. 2026 Jun 21:2690805. doi: 10.1080/21505594.2026.2690805. Online ahead of print.ABSTRACTLyme disease (LD) represents a significant public health challenge in North America and Eurasia. The […]
- Using Electronic Health Records to Enhance Lyme Disease Surveillance: Protocol for the SubLyme Networkon 17 juillet 2026
JMIR Res Protoc. 2026 Jul 8;15:e94921. doi: 10.2196/94921.ABSTRACTBACKGROUND: Lyme disease is the most common vector-borne illness in the United States. The limitations of traditional surveillance […]
- Single-step immunoblot tests with recombinant protein antigens for detecting IgG and IgM antibodies in Lyme diseaseon 17 juillet 2026
Microbiol Spectr. 2026 Jul 15:e0019926. doi: 10.1128/spectrum.00199-26. Online ahead of print.ABSTRACTSerodiagnosis is important in Lyme disease (LD). Until recently, this commonly required two […]
- Lyme Disease Knowledge, Attitudes, and Practices Among Surveyed Clinicians in Western North Carolina, 2022-2023on 2 juin 2026
Vector Borne Zoonotic Dis. 2026 May 23:15303667261453194. doi: 10.1177/15303667261453194. Online ahead of print.ABSTRACTINTRODUCTION: Lyme disease has expanded into western North Carolina. We sought […]
- Lyme disease as a rare trigger for autoimmune hemolytic anemiaon 15 mai 2026
Lyme disease, caused by Borrelia burgdorferi, is a zoonotic infection affecting the skin, nervous system, joints, and heart. Diagnosis relies on clinical history, symptoms, and a two steps serologic […]
- Sex and menopause-based differences in presentation of early Lyme disease: A prospective cohort studyon 15 mai 2026
Although prior research has established sex and menopausal status-based differences in immune response, susceptibility, and severity to a variety of pathogens, their relevance in early Lyme disease […]
- Spatial modeling of Borrelia genospecies in human-biting ticks from the French citizen science programme CiTIQUEon 15 mai 2026
Sci Rep. 2026 Apr 21;16(1):12919. doi: 10.1038/s41598-026-42619-4.ABSTRACTIn Europe, Lyme borreliosis is the most common vector-borne human disease, mainly caused by Borrelia afzelii and Borrelia […]
- Lyme Neuroborreliosis With Acute Encephalopathy Despite Early Antibiotic Therapy: A Case Reporton 10 avril 2026
Am J Case Rep. 2026 Apr 6;27:e951927. doi: 10.12659/AJCR.951927.ABSTRACTBACKGROUND Lyme disease is a tick-borne infection caused by spirochetes of the Borrelia burgdorferi sensu lato species complex […]
- Lyme borreliosison 10 avril 2026
Nat Rev Dis Primers. 2026 Mar 26;12(1):15. doi: 10.1038/s41572-026-00691-0.ABSTRACTLyme borreliosis is the most common tick-borne disease in the northern hemisphere. It is a zoonosis caused by […]
- Evaluation of immunoreactive epitopes in the sera and cerebrospinal fluid of patients with post-treatment Lyme disease syndromeon 16 mars 2026
Sci Rep. 2026 Mar 13. doi: 10.1038/s41598-026-42941-x. Online ahead of print.NO ABSTRACTPMID:41826406 | DOI:10.1038/s41598-026-42941-x
- Pilot study of psilocybin in patients with post-treatment lyme diseaseon 16 mars 2026
Sci Rep. 2026 Feb 25;16(1):7497. doi: 10.1038/s41598-026-38091-9.ABSTRACTLyme disease, caused by the bacterium Borrelia burgdorferi, is the most common vector-borne disease in the United States and […]
- EXPRESS: A Comprehensive Review of Lyme disease in Latin Americaon 16 mars 2026
J Investig Med. 2026 Feb 25:10815589261429530. doi: 10.1177/10815589261429530. Online ahead of print.ABSTRACTLyme disease (LD) is caused by a bacterial genospecies complex named Borrelia burgdorferi […]
- Lyme Disease and Health Care Costson 6 février 2026
JAMA Netw Open. 2026 Jan 2;9(1):e2552518. doi: 10.1001/jamanetworkopen.2025.52518.ABSTRACTIMPORTANCE: Lyme disease (LD) is the most common vector-borne illness in the US. Given the increasing […]
- Deficiencies in communication between clinical microbiological laboratories and physicians may impair the diagnosis of Lyme borreliosis: A study of the use and application of serology in three neighbouring counties in Swedenon 6 février 2026
PLoS One. 2025 Dec 26;20(12):e0339449. doi: 10.1371/journal.pone.0339449. eCollection 2025.ABSTRACTPURPOSE: The diagnosis of Lyme borreliosis (LB) can be challenging. The aim of this study was to […]
- A human Lyme disease vaccine: two steps forward on the path to preventionon 6 février 2026
Expert Rev Vaccines. 2026 Dec;25(1):2607482. doi: 10.1080/14760584.2025.2607482. Epub 2025 Dec 25.ABSTRACTINTRODUCTION: Lyme disease is caused by the tick-borne spirochete pathogen Borrelia […]
- Deficiencies in communication between clinical microbiological laboratories and physicians may impair the diagnosis of Lyme borreliosis: A study of the use and application of serology in three neighbouring counties in Swedenon 9 janvier 2026
PLoS One. 2025 Dec 26;20(12):e0339449. doi: 10.1371/journal.pone.0339449. eCollection 2025.ABSTRACTPURPOSE: The diagnosis of Lyme borreliosis (LB) can be challenging. The aim of this study was to […]
- Early brain changes in Lyme disease are associated with clinical outcomeson 9 janvier 2026
Brain Behav Immun Health. 2025 Dec 2;50:101153. doi: 10.1016/j.bbih.2025.101153. eCollection 2025 Dec.ABSTRACTIn Lyme disease (LD), 10-20 % of patients develop persistent symptoms following […]
- A human Lyme disease vaccine: two steps forward on the path to preventionon 9 janvier 2026
Expert Rev Vaccines. 2025 Dec 21:2607482. doi: 10.1080/14760584.2025.2607482. Online ahead of print.ABSTRACTINTRODUCTION: Lyme disease is caused by the tick-borne spirochete pathogen Borrelia […]
- Guidelines for Lyme borreliosis: treatmenton 9 janvier 2026
Infect Dis Now. 2025 Dec;55(8S):105204. doi: 10.1016/j.idnow.2025.105204. Epub 2025 Nov 26.ABSTRACTThe aim of the clinical practice guideline is to support healthcare professionals in the diagnosis […]
- Guidelines for Lyme borreliosis: clinical manifestationson 9 janvier 2026
Infect Dis Now. 2025 Dec;55(8S):105202. doi: 10.1016/j.idnow.2025.105202. Epub 2025 Nov 28.ABSTRACTLyme borreliosis (LB) is a tick-borne zoonosis caused by spirochetes belonging to the Borrelia […]
Encéphalomyélite myalgique
- PTPRN2 hypomethylation and PHB2-associated miR-153-3p maturation define dual epigenetic features linked to symptom variability in Myalgic encephalomyelitison 17 juillet 2026
Author Names: Chalder, L.,Elremaly, W.,Caraus, I.,Leveau, C.,Franco, A.,Nepotchatykh, E.,Rostami-Afshari, B.,Gimenez, M.,Li, D.,Fang, Y.,Elbakry, M.,Godbout, C.,Di Tomasso, G.,Legault, […]
- Multimodal approach to identify neuropsychophysiological subgroups in myalgic encephalomyelitis/chronic fatigue syndrome and their relevance for rehabilitation: protocol for a mechanistic cross-sectional and longitudinal studyon 17 juillet 2026
Author Names: Dooms, Y.,Qiu, L.,Van Den Houte, M.,Coppieters, I.,Vergaelen, E.,Claes, S.,Dupont, P.,Cuypers, K.,Engler, H.,Dombrowski, K.,Verbeke, K.,Van den Bergh, O.,Bogaerts, K.,Raes, J.,Van […]
- Association between light exposure patterns and multidimensional health outcomes in individuals with myalgic encephalomyelitis/chronic fatigue syndrome: findings from an observational cross-sectional cohort studyon 17 juillet 2026
J Transl Med. 2026 Jul 3. doi: 10.1186/s12967-026-08556-6. Online ahead of print.ABSTRACTBACKGROUND: Light is a major environmental factor regulating circadian rhythms, sleep- wake cycles, and […]
- Tryptophan Metabolism and Aryl-Hydrocarbon Receptor Agonists in the Gut Microbiome of People With Myalgic Encephalomyelitis/Chronic Fatigue Syndromeon 17 juillet 2026
Microbiologyopen. 2026 Jun;15(3):e70333. doi: 10.1002/mbo3.70333.ABSTRACTMyalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating chronic disease with unknown biological basis […]
- Effectiveness of adapted physical activity and therapeutic exercise programme in improving chronic fatigue syndrome in long COVID, delivered via hospital-based rehabilitation versus telerehabilitationon 17 juillet 2026
Trials. 2026 Jun 17. doi: 10.1186/s13063-026-09769-2. Online ahead of print.ABSTRACTBACKGROUND: Long COVID is a prevalent condition characterised by pain, fatigue, disability, and a multitude of […]
- Components and Delivery Formats of Cognitive Behavioral Therapy for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Systematic Review and Component Network Meta-Analysison 2 juin 2026
Brain Behav. 2026 Jun;16(6):e71513. doi: 10.1002/brb3.71513.ABSTRACTOBJECTIVE: Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a debilitating condition characterized by persistent […]
- Deficient TRPM3-linked mitochondrial Ca(2+) influx in natural killer cells associated with myalgic encephalomyelitis/chronic fatigue syndromeon 2 juin 2026
BMC Immunol. 2026 May 23. doi: 10.1186/s12865-026-00849-1. Online ahead of print.ABSTRACTINTRODUCTION: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a multisystemic illness, commonly […]
- Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Successful Therapeutic Plasma Exchange Treatment After SARS-CoV-2 Infection-A Case Reporton 2 juin 2026
Clin Case Rep. 2026 May 17;14:e72725. doi: 10.1002/ccr3.72725. eCollection 2026 May.ABSTRACTMyalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex neuroimmunological disorder […]
- Chronic fatigue syndrome in nursing practice: a concept analysison 2 juin 2026
BMC Nurs. 2026 May 15. doi: 10.1186/s12912-026-04749-y. Online ahead of print.ABSTRACTBACKGROUND: Nurses are essential in chronic fatigue syndrome (CFS) management, serving as care coordinators and […]
- Underuse of Pharmacologic Therapies for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Before Specialist Evaluationon 15 mai 2026
Ann Fam Med. 2026 Apr 29:250266. doi: 10.1370/afm.250266. Online ahead of print.ABSTRACTPURPOSE: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a multisystem neurologic disease […]
- The efficacy of exercise in patients with myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and meta-analysison 15 mai 2026
J Psychosom Res. 2026 Apr 15;207:112677. doi: 10.1016/j.jpsychores.2026.112677. Online ahead of print.ABSTRACTOBJECTIVE: To evaluate the efficacy of exercise training for patients with myalgic […]
- Comparing ME/CFS following mononucleosis with Long COVIDon 15 mai 2026
Chronic Illn. 2026 Apr 15:17423953251347108. doi: 10.1177/17423953251347108. Online ahead of print.ABSTRACTObjectivesLong COVID following SARS-CoV-2 and Myalgic Encephalomyelitis/Chronic Fatigue […]
- Expert perspectives on Myalgic encephalomyelitis/chronic fatigue syndrome - Insights from the 3(rd) International Conference of the Charite Fatigue Centeron 10 avril 2026
Autoimmun Rev. 2026 Mar 25:104043. doi: 10.1016/j.autrev.2026.104043. Online ahead of print.ABSTRACTMyalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, multisystemic disorder […]
- Likely neurodivergence and variant connective tissue in patients with chronic pain/chronic fatigue: a case-control studyon 10 avril 2026
J Psychiatr Res. 2026 Jun;197:125-132. doi: 10.1016/j.jpsychires.2026.02.036. Epub 2026 Feb 18.ABSTRACTNeurodivergent traits are frequently observed in individuals with chronic pain and/or chronic […]
- Exercise interventions for physical function, psychological health, and quality of life in patients with myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia: A systematic review and network meta-analysison 10 avril 2026
J Psychosom Res. 2026 Mar 5;206:112618. doi: 10.1016/j.jpsychores.2026.112618. Online ahead of print.ABSTRACTBACKGROUND: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and fibromyalgia […]
- Postural Orthostatic Tachycardia Syndrome, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID as Neuroimmune Disorderson 10 avril 2026
Immunotargets Ther. 2026 Feb 2;15:581262. doi: 10.2147/ITT.S581262. eCollection 2026.ABSTRACTPostural orthostatic tachycardia syndrome (POTS), myalgic encephalomyelitis/chronic fatigue syndrome […]
- ACHTSAM study protocol: outreach diagnostics and assessment of tolerability in severe ME/CFS-a pilot studyon 10 avril 2026
Author Names: Fricke C.,Deibert P.,Maier P.,Kern W.,Krumnau O.,Barsch F. Database Source: Embase Daily Updates Journal Title: BMJ open […]
- Evidence of White Matter Neuroinflammation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Diffusion-Based Neuroinflammation Imaging Studyon 16 mars 2026
Hum Brain Mapp. 2026 Mar;47(4):e70505. doi: 10.1002/hbm.70505.ABSTRACTMyalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disorder with suspected neuroinflammatory […]
- Effect of Prolong Life With Nine Turn Method on chronic fatigue syndrome clinical symptoms and roles of gut microbiota: a exploratory randomized controlled trialon 16 mars 2026
Complement Ther Med. 2026 Mar 8:103353. doi: 10.1016/j.ctim.2026.103353. Online ahead of print.ABSTRACTBACKGROUND: Traditional Chinese Qigong exercises (Prolong Life With Nine Turn Method) are […]
- Chronic fatigue syndrome: From etiology and mechanism to diagnosis and treatmenton 16 mars 2026
J Psychiatr Res. 2026 Feb 13;196:171-184. doi: 10.1016/j.jpsychires.2026.02.026. Online ahead of print.ABSTRACTMyalgic encephalomyelitis (ME), commonly known as chronic fatigue syndrome (CFS), is a […]
CCAI
- Designing studies for post-treatment Lyme disease and other infection-associated chronic illnesses - PubMedon 17 juillet 2026
Infection-associated chronic illnesses (IACIs) encompass a spectrum of poorly understood syndromes often marked by significant neurologic and multisystem symptoms following an infectious event. This […]
- Persistent physical symptoms not explained by structural abnormalities or disease processes: a primary care approach to promote recovery - PubMedon 10 avril 2026
Background: A substantial proportion of people consulting primary care practitioners have symptoms that persist even after structural problems and diseases have been excluded. They experience […]
- Seeing the forest through the trees: Harmonizing infection-associated chronic illnesses researchon 16 mars 2026
Proc Natl Acad Sci U S A. 2026 Feb 24;123(8):e2600628123. doi: 10.1073/pnas.2600628123. Epub 2026 Feb 18.NO ABSTRACTPMID:41706889 | DOI:10.1073/pnas.2600628123
- Progress Toward Understanding Infection-Associated Chronic Conditions and Illnesses - PubMedon 6 février 2026
Display options Format AbstractPubMedPMID No abstract available Keywords: COVID-19; IACCI; Infection-associated chronic conditions and infections; Long COVID; bacteria; chronic fatigue syndrome; […]
- Long COVID as an Infection-Associated Chronic Condition: Implicationson 6 février 2026
Am J Health Promot. 2025 Jul;39(6):960-965. doi: 10.1177/08901171241308066b. Epub 2025 Jun 8.ABSTRACTA link between infection and chronic illness has been recognized, along with the complexities of […]
Études cliniques
- Nutritional Intervention and Rehabilitation Treatment in Patients With Post-COVID Conditionon 17 juillet 2026
Conditions: Post-COVID Condition Interventions: Dietary Supplement: Active; Other: Placebo Sponsors: Instituto de Investigación Sanitaria Aragón; Solutex GC S.L. Completed
- LYT-100 in Post-acute COVID-19 Respiratory Diseaseon 17 juillet 2026
Conditions: Covid19; Post-acute COVID-19 Respiratory Disease Interventions: Drug: LYT-100; Other: Placebo Sponsors: PureTech; Clinipace Worldwide; Novotech (Australia) Pty Limited Terminated
- Taurine Supplementation in Adolescents With Post-COVID Conditionon 17 juillet 2026
Conditions: Long COVID; Post COVID-19 Condition; PASC Post Acute Sequelae of COVID 19 Interventions: Drug: Taurine Sponsors: University of Alberta; Canadian Institutes of Health Research (CIHR) […]
- A Pilot Randomized Controlled Trial of Homeopathic Treatment for Long COVIDon 17 juillet 2026
Conditions: Long COVID; Long COVID Symptoms Interventions: Other: Treatment A: Treatment by a homeopath prescribing a specific homeopathic remedy for long COVID; Other: a course of individually […]
- Fatigue in Long COVIDon 17 juillet 2026
Conditions: Long COVID Interventions: Behavioral: Lightning Process; Other: Activity Pacing Sponsors: McMaster University; Hamilton Academic Health Sciences Organization Not yet recruiting
- Cardiovascular Assessment 5 Years After MIS-Con 17 juillet 2026
Conditions: Multisystem Inflammatory Syndrome in Children (MIS-C); SARS-CoV-2 Infection Sponsors: Medical University of Warsaw Recruiting
- PERCEIVE-Outreach: A Scalable, Risk-Based Model for Managing Persistent Cardiovascular Impact in Long COVIDon 17 juillet 2026
Conditions: Long COVID Interventions: Other: PERCEIVE-Outreach Intervention Sponsors: University of Tasmania; Baker Heart and Diabetes Institute; Ochre Health Recruiting
- The Efficacy of Long-Chain Fatty Acids, Eicosapentaenoic Acid (EPA) and Specialized Pro-Resolving Mediators (SPMs), in Treating Long COVID Neuropsychiatric Symptoms: A Double-Blind Placebo-Controlled Clinical Trial and Analysis of Inflammatory Markers and Microbiomeon 17 juillet 2026
Conditions: COVID - 19; Depression - Major Depressive Disorder Interventions: Dietary Supplement: Eicosapentaenoic acid (omega-3 fatty acid); Dietary Supplement: Specialized Pro-Resolving Lipid […]
- Transcranial Direct Current Stimulation for Long COVID Brain Fog and Fatigueon 17 juillet 2026
Conditions: Long COVID; Post-COVID Conditions; Fatigue; Cognitive Dysfunction Interventions: Device: Transcranial Direct Current Stimulation Sponsors: University of Las Palmas de Gran Canaria; […]
- Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitationon 17 juillet 2026
Conditions: Chronic Fatigue Syndrome; COVID-19, Long Haul Interventions: Drug: Pregabalin; Behavioral: Independent walking training; Drug: Placebo; Behavioral: Gradual movement therapy in the ward; […]
- Effect of a Non-pharmacological Intervention on Endothelial Function, Body Composition, and Physical Functionality in Recovered COVID-19 Patients.on 15 mai 2026
Conditions: Supplemental Nutrition Assistance Program Education; Post COVID Syndrome; Endothelial Function Interventions: Dietary Supplement: L-citrulline supplementation Sponsors: Instituto […]
- Physical Functions and Lifestyle Behaviours in Post-COVID-19 Syndrome Based on Circadian Rhythmson 15 mai 2026
Conditions: Post-COVID-19 Syndrome Sponsors: Hacettepe University Recruiting
- COVID-19 Outcome Prediction Algorithmon 15 mai 2026
Conditions: COVID-19; Post Acute Sequelae of COVID-19; Long COVID; Organ Dysfunction Syndrome, Multiple; Frailty Syndrome Interventions: Other: Blood and nasal swab sampling Sponsors: University of […]
- Tele-exercise Training Program for Long COVIDon 15 mai 2026
Conditions: Long COVID Interventions: Device: Telehealth exercise training program; Behavioral: Education and self-exercise Sponsors: Tri-Service General Hospital Completed
- Diagnostic and Clinical Management of Non-Obstructive Myocardial Ischemia in Patients With Long Covid-19 Syndrome and New Onset Chest Painon 15 mai 2026
Conditions: Angina (Stable); INOCA (Ischemia With Non Obstructive Coronary Artery Disease); Long COVID-19 Syndrome Interventions: Diagnostic Test: Coronary functional test Sponsors: Fundacion […]
- Acute Metabolic Outcomes in Diabetic Patients Hospitalized for COVID-19 (DMD-COV)on 15 mai 2026
Conditions: Diabetes Mellitus; COVID-19; Post-Acute COVID-19 Syndrome Interventions: Other: No intervention (observational study) Sponsors: Algerian Society of Diabetology; Novo Nordisk A/S; […]
- Institut de Recherche Cliniques de Montreal (IRCM) Post-COVID-19 (IPCO) Research Clinicon 15 mai 2026
Conditions: Covid19; Long COVID Interventions: Other: Medical follow-up Sponsors: Emilia Falcone, MD Recruiting
- DMSO Dual-Route Therapy for Refractory Tinnitus in Long-COVID and Post-COVID-19 Vaccine Injuryon 15 mai 2026
Conditions: Tinnitus Interventions: Drug: DMSO-based otic solution with betahistine, dexamethasone, and lidocaine; Drug: DMSO-based transdermal cream with levocarnitine and N-acetylcysteine […]
- Understanding the Long-term Impact of COVID-19 in Adultson 10 avril 2026
Conditions: Long COVID; Long Covid19 Sponsors: NYU Langone Health; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting
- Disability Following Hospitalization in People of Working-age Surviving SARS-CoV-2 Infection - COVID-19on 10 avril 2026
Conditions: COVID-19 Interventions: Other: Hospitalization Sponsors: Assistance Publique - Hôpitaux de Paris; URC-CIC Paris Descartes Necker Cochin Completed
Formation continue
- Canadian Tick-Borne Disease Conferenceon 17 juillet 2026
Join us for the second annual Canadian Tick-Borne Disease Conference exclusively for medical practitioners. Taking place in Toronto, the CTD Conference will allow you to hear the latest on […]
- 2026 Symposiumon 17 juillet 2026
Long COVID Web is pleased to announce the 4th Canadian Symposium on Long COVID. The Symposium will bring together people with lived experience of Long COVID, clinicians, trainees, allied health, […]
- Canadian Symposium on Long COVID - Institute of Health Policy, Management and Evaluationon 17 juillet 2026
On behalf of Long COVID Web… Registration is now open for the 4th Canadian Symposium on Long COVID, co-organized by Long COVID Web in collaboration with local planning committee members. The […]
- 4th Long COVID International Conference 2026on 17 juillet 2026
This conference aims to raise awareness, clarify misconceptions, promote understanding, and stimulate discussion amongst healthcare professionals, investigators, policymakers, and community […]
- 3rd Long COVID International Conference 2025on 15 mai 2026
- 3rd Canadian Symposium on Long COVID | Cross-Pillar Discussionon 15 mai 2026
This closing session brings together voices from research, clinical practice, and lived experience to reflect on the key insights and lessons shared throughout the 3rd Canadian Symposium on Long […]
- ISLC-PAIS Conference 2026 in Amsterdamon 15 mai 2026
26 – 29 August, 2026 Amsterdam (the Netherlands) Join Lionhearted ScienceUnited Against Long COVID & PAIS Post-Acute Infection Syndromes (PAIS), including Long COVID, are among the most […]
- 4th Long COVID International Conference 2026on 15 mai 2026
This conference aims to raise awareness, clarify misconceptions, promote understanding, and stimulate discussion amongst healthcare professionals, investigators, policymakers, and community […]
- International ME/CFS Conference 2026on 10 avril 2026
Under the stewardship of Prof Carmen Scheibenbogen, Director of the Division of Immunodeficiencies and Post-infectious Diseases and the Charité Fatigue Center (CFC) at Charité – […]
- 2025 Symposiumon 10 avril 2026
Emera Innovation Exchange, Signal Hill Campus, Memorial University St. John’s, Newfoundland. Background Long Covid Web and Memorial University of Newfoundland are pleased to announce the […]
- Entrez dans le labyrinthe de Lyme - Radio-Canadaon 16 mars 2026
Entrez dans le labyrinthe de Lyme Radio-Canada
- 2026_Program_LTBDI_Symposium.pdfon 6 février 2026
- Looking at the Pandemic in the Rearview Mirror: Successes, Failures and Unintended Consequences. Conference, May 2025.on 6 février 2026
Supporting the generation of high-quality evidence for public health emergencies. Fostering effective and efficient knowledge exchange for global public health emergencies. Inspiring policymakers […]
- 2026 International Forum on COVID Rehabilitation Researchon 6 février 2026
Rob Wüst is an Associate Professor at the Faculty of Behavioral and Movement Sciences at the Vrije Universiteit Amsterdam. His research group studies skeletal and cardiac muscle metabolism and […]
- 2026 Symposiumon 6 février 2026
Long Covid Web and the University of British Columbia are pleased to announce the 2026 Canadian Symposium on Long COVID. The Symposium will bring together people with lived experience of Long COVID, […]
Revue d'actualités
- Comment les tiques transmettent-elles des maladies en forêt? - Le Devoiron 17 juillet 2026
Comment les tiques transmettent-elles des maladies en forêt? Le Devoir
- Les spécialistes lancent un avertissement : cette maladie transmise par les tiques augmente rapidement au Québec et ses symptômes ressemblent à une simple grippe - Salut Bonjouron 17 juillet 2026
Les spécialistes lancent un avertissement : cette maladie transmise par les tiques augmente rapidement au Québec et ses symptômes ressemblent à une simple grippe Salut Bonjour
- Mordue par une tique, elle devient allergique à la viande - Radio-Canadaon 17 juillet 2026
Mordue par une tique, elle devient allergique à la viande Radio-Canada
- Les tiques gagnent du terrain dans nos régions - Radio-Canadaon 17 juillet 2026
Les tiques gagnent du terrain dans nos régions Radio-Canada
- La maladie de Lyme bat des records à Montréal - Le Journal de Montréalon 2 juin 2026
La maladie de Lyme bat des records à Montréal Le Journal de Montréal
- Bientôt un vaccin contre les maladies transmises par les tiques? - Radio-Canadaon 2 juin 2026
Bientôt un vaccin contre les maladies transmises par les tiques? Radio-Canada
- Lyme disease cases in England rise 20% in a yearon 2 juin 2026
BMJ. 2026 May 26;393:e180319. doi: 10.1136/bmj-2026-180319.NO ABSTRACTPMID:42191169 | DOI:10.1136/bmj-2026-180319
- Long Covid Service Extended to Cover Wider Range of Conditions - NHS Forth Valleyon 15 mai 2026
Long Covid Service Extended to Cover Wider Range of Conditions NHS Forth Valley
- Long COVID: 3 years in - The Lanceton 15 mai 2026
Long COVID: 3 years in The Lancet
- Une experte déplore l’arrêt du rapport provincial sur la surveillance des tiques - Radio-Canadaon 15 mai 2026
Une experte déplore l’arrêt du rapport provincial sur la surveillance des tiques Radio-Canada
- Designing Nutrition Studies for Long COVID and Related Infection-Associated Chronic Illness: Qualitative Insights From a Patient-Reported Evaluation of Ketogenic Metabolic Therapyon 15 mai 2026
J Patient Exp. 2026 Apr 13;13:23743735261442541. doi: 10.1177/23743735261442541. eCollection 2026.ABSTRACTBACKGROUND: Long COVID affects over 400 million people worldwide and has no FDA-approved […]
- COVID longue | Une équipe de l’IRCM est sur une nouvelle piste - La Presseon 15 mai 2026
COVID longue | Une équipe de l’IRCM est sur une nouvelle piste La Presse
- 1400 jours avec la COVID longue; les dernières découvertes pour l’espoir de guérir - Radio-Canadaon 15 mai 2026
1400 jours avec la COVID longue; les dernières découvertes pour l’espoir de guérir Radio-Canada
- La COVID longue coûtera des milliards au cours de la prochaine décennie, avertit l’OCDE - Radio-Canadaon 15 mai 2026
La COVID longue coûtera des milliards au cours de la prochaine décennie, avertit l’OCDE Radio-Canada
- Une exposition d’art dévoile les défis quotidiens du syndrome de fatigue chronique - Radio-Canadaon 15 mai 2026
Une exposition d’art dévoile les défis quotidiens du syndrome de fatigue chronique Radio-Canada
- De l'espoir pour le syndrome de fatigue chronique, une maladie multisystémique - Psychomédiaon 15 mai 2026
De l'espoir pour le syndrome de fatigue chronique, une maladie multisystémique Psychomédia
- Disperser le brouillard autour de l’encéphalomyélite myalgique - Université de Montréalon 15 mai 2026
Disperser le brouillard autour de l’encéphalomyélite myalgique Université de Montréal
- New McGill University study seeks to better understand the lingering symptoms of long COVID - CBCon 10 avril 2026
New McGill University study seeks to better understand the lingering symptoms of long COVID CBC
- Un antidépresseur pourrait traiter les symptômes de fatigue liés à la COVID longue, selon une étude - Noovo Infoon 10 avril 2026
Un antidépresseur pourrait traiter les symptômes de fatigue liés à la COVID longue, selon une étude Noovo Info
- Restructuration des soins pour les patients atteints de COVID de longue durée - Radio-Canadaon 10 avril 2026
Restructuration des soins pour les patients atteints de COVID de longue durée Radio-Canada
Pour obtenir les documents
L’accès au texte intégral des documents est restreint au personnel et aux médecins du CHUM en fonction des abonnements de la bibliothèque. Certains documents sont en accès libre sur le web.
Si vous êtes branchés sur le réseau CHUM :
Cliquer sur les liens fournis pour chaque référence pour vérifier la disponibilité du texte intégral.
Pour les articles provenant de PubMed, cliquer préalablement sur le lien suivant pour afficher la disponibilité du document.
Si vous êtes dans un autre établissement et que vous n’arrivez pas à accéder au texte intégral d’un article à partir du lien donné, vérifier auprès de la bibliothèque de votre institution en donnant la référence complète du document.
|
Avis de non-responsabilité
Le contenu des veilles informationnelles ou stratégiques (ci-après appelée « Veilles ») est mis à votre disposition à titre informatif pour un usage personnel exclusif. Tout usage commercial du contenu des Veilles est strictement interdit. Tous les éléments, articles, rapports ou toute autre source d’information figurant dans les Veilles, vous sont fournis « tels quels », sans garantie d’aucune sorte. Eu égard aux propos tenus dans les articles et les rapports sélectionnés pour les Veilles, le CHUM n’offre aucune garantie notamment d’exhaustivité, de fiabilité, d’actualité et d’exactitude.Le CHUM ne pourra en aucun cas être tenu responsable envers quiconque de tout dommage quel qu’il soit, même ceux directs, encouru notamment des suites de toute réclamation, action ou poursuite découlant, même directement, de l’utilisation de ces Veilles.
Les Veilles contiennent des liens vers des sites Web créés et mis à jour par des tierces parties. Ces liens sont fournis pour la commodité des utilisateurs seulement. Le CHUM n’endosse et ne garantit, ni explicitement ni implicitement, l’exactitude ou l’intégralité ni du contenu de ces hyperliens ni des opinions qui y sont exprimées. Le CHUM n’assume aucune responsabilité à l’égard de ces sites Web externes.
Le CHUM prend tous les moyens raisonnables afin de respecter les droits de propriété intellectuelle afférents au contenu des Veilles et aux modalités du prêt entre bibliothèques, émises par l’Université de Montréal. Le contenu des Veilles, incluant la manière dont il est présenté, sont notamment protégés par la Loi sur le droit d’auteur (L.R.C. (1985), ch. C-42). Le CHUM ne donne aucune garantie et ne fait aucune déclaration à l’effet que le contenu de ces veilles n’enfreint aucun droit d’une autre personne ou entité. Le téléchargement, la reproduction en un seul exemplaire ou le tirage sur papier des Veilles ne sont autorisés qu’à des fins de sauvegarde et pour un usage privé et non commercial. Tout téléchargement, reproduction, édition, diffusion sur Internet, utilisation à des fins commerciales ou publiques, distribution, publication sur un autre site ou sur quelque autre forme ainsi que toute autre utilisation est strictement interdite, à moins d’être faite dans le respect des règles de propriété intellectuelle applicables. |


